Petmed Express Inc 's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Petmed Express Inc 's ROA in the first quarter of 2026?
Petmed Express Inc recorded a cumulative net loss of $-29 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -29.73%.

However, within the Retail sector 165 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3952, from total ROA ranking in the fourth quarter of 2026 at 4604.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Total Assets Change	-41.95 %	-45.4 %	-10.4 %	-29.19 %	-25.48 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-29	-57	-65	-55	-44
Return On Assets (TTM)	-29.73 %	-52.07 %	-51.12 %	-41.94 %	-31.21 %
PETS's Total Ranking	# 3952	# 4604	# 3920	# 3804	# 3001
Total Assets (TTM) in million	64	81	149	100	110
Seq. Total Assets Change	-21.47 %	-45.4 %	48.25 %	-8.68 %	-26.13 %
Seq. Net Income Change	-	-	-	-	-

PETS's 5 Years Annual ROA >> Back to PETS Management Effectiveness >> Compare PETS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 8
Sector	# 166
Overall	# 3602

Return On Assets Statistics
High	Average	Low
31.06 %	11.53 %	-52.07 %
(Sep 30 2018)		(Mar 31 2026)

Financial Statements
Petmed Express Inc 's Assets	$ 64 million	PETS's Balance sheet
Petmed Express Inc 's Income	$ -6 million	Quarterly PETS's Income Statement
PETS's Income by Division		See PETS's Income by Division

Annual Return On Assets	(Mar 31 2026) FY 2026	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022
Y / Y Total Assets Change	-45.4 %	-10.4 %	1.76 %	-7.5 %	-5.96 %
Total Assets in million	81	149	166	163	176
Y / Y Net Income Change	-	-	-	-75.64 %	-31.05 %
Net Income in million	-57	-6	-7	5	21
Annual Return On Assets	-70.56 %	-4.22 %	-4.5 %	3.15 %	11.97 %

PETS's 5 Years Annual ROA >> Back to PETS Management Effectiveness >> Compare PETS ROA to its Competitors

More Return On Assets Ratios
PETS's' Return on Assets at Yahoo Finance
Pharmacy Services & Retail Drugstore Industry Return On Assets Trends and Statistics
Retail Sector Roa Statistics
Roa Trends for overall market
PETS's Roa Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PETS's Competitors
Subscribers only: Roa for Petmed Express Inc 's Suppliers
Subscribers only: Return On Assets for PETS's Customers

You may also want to know
PETS's Roi	PETS's Inventory Turnover Ratio	PETS's Growth Rates	PETS's Dividend Comparisons
	PETS's Profitability Ratios	PETS's Asset Turnover Ratio	PETS's Dividend Growth
PETS's Roe	PETS's Valuation Ratios	PETS's Financial Strength Ratios	PETS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Retail Sector

ROA

Date modified: 2026-09-08T21:35:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.